Marcus Bosenberg - Concepedia

Author

Marcus Bosenberg

Also Known As

Arndt Borkhardt, Bogner, P.N., Busam, K.J., Christoph Borst, Ivan Borozan, M Bosenberg, M Bösenberg, M. Bosenberg, M.W. Bosenberg, Marcus W. Bosenberg

630

Publications

36.3K

Citations

H-Index

135

Concepts

All Affiliations

Yale University Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital Massachusetts General Hospital

About

Marcus Bosenberg is an author at Yale University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	76	16.7K
2	Health Sciences	5	5	281
3	Natural Sciences	4	4	620
4	Allergy	3	3	451
5	Engineering	2	2	58

Marcus Bosenberg

157

Publications

28.6K

Citations

H-Index

Page 1

	Year	Citations
Genomic Classification of Cutaneous Melanoma Rehan Akbani, Kadir C. Akdemir, Bülent Arman Aksoy, Cell Dermoscopic ImageSkin CancerMedicineMelanomaPathology	2015	3.2K
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy Weiyi Peng, Jie Qing Chen, Chengwen Liu, Cancer Discovery	2015	1.5K
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses Ping‐Chih Ho, Jessica Bihuniak, Andrew N. Macintyre, Cell Energy MetabolismSignal TransductionBiochemistryCatabolismCell Death	2015	1.4K
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma Michael Krauthammer, Yong Kong, Byung Hak Ha, Nature Genetics Somatic VariantMedicineMelanomaCancer GeneticsMolecular Diagnostics	2012	1.2K
BrafV600E cooperates with Pten loss to induce metastatic melanoma David Dankort, David P. Curley, Robert A Cartlidge, Nature Genetics MelanomaTumor SuppressorPten LossMedicineCell Biology	2009	1.2K
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition Hélène Salmon, Juliana Idoyaga, Adeeb Rahman, Immunity Cancer ImmunosurveillanceTherapeutic Pd-l1MedicineBraf InhibitionImmunology	2016	1.1K
Deregulated Akt3 Activity Promotes Development of Malignant Melanoma Jill M. Stahl, Arati Sharma, Mitchell Cheung, Cancer Research	2004	576
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans K. Lenhard Rudolph, Melissa Millard, Marcus Bosenberg, Nature Genetics Oncogenic AgentMedicinePathologyColorectal CancerTelomere Dysfunction	2001	518
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours Eric Song, Tianyang Mao, Huiping Dong, Nature Neuro-oncologyVegf-c-driven Lymphatic DrainageImmunologyLymphatic SystemLymphatic Disease	2020	504

Page 1